Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz
Texas Gov. Greg Abbott asked the federal government for $11 billion as a reimbursement for the border security measures he ...
Fox Business on MSN1d
What should investors watch this week?
FOX Business' Taylor Riggs takes a look at shares from Texas Instruments, Novo Nordisk and Intuitive Surgical on 'The Claman ...
Donald Trump in fiery call with Denmark’s prime minister over Greenland
Donald Trump insisted he was serious in his determination to take over Greenland in a fiery telephone call with Denmark’s ...
Danish prime minister clashes with Trump over Greenland
Mr Trump spoke to Mette Frederiksen, the Danish premier, for 45 minutes last week. The White House has not commented on the ...
Trump Triggers a Crisis in Denmark—And Europe
"Trump might forget about Greenland. But also, he might not. Nobody knows. He operates on whims," @anneapplebaum writes.
Jim Cramer’s Comments on Novo Nordisk A/S (NVO) Surrounded Its Weight Loss Drugs Being Picked For Medicare Price Negotiations
We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...
World’s largest offshore wind farm maker Orsted takes fresh $1.7 billion write-down in the U.S. as its Trump nightmare begins
Orsted’s Sunrise Wind project, a 924-megawatt offshore wind farm in New York meant to power 600,000 homes, is expected to ...
Richard Nixon’s third term on trade starts today
This article is an on-site version of our Trade Secrets newsletter. Premium subscribers can sign up here to get the newsletter delivered every Monday. Standard subscribers can upgrade to Premium here, ...
Novo Nordisk next-gen shot shows 22% weight loss in early results
One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...
STAT1d
Novo Nordisk’s next-generation obesity treatment shows promise in early study
A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...
STAT1d
Novo Nordisk is slammed by U.K. trade group for not disclosing payments to health and patient groups
Novo Nordisk was slammed by a U.K. trade group for not disclosing payments to health and patient groups, according to a draft ...
The Motley Fool5d
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...